Does the Geko nerve stimulator reduce Deep Vein Thrombosis (DVT) and improve healing in ankle fractures?

Completed

• Conditions: Ankle fracture; Injury, Occupational Diseases, Poisoning; Fractures of other parts of lower leg

• Registration Number: ISRCTN95441725
• Lead Sponsor: Wirral University Teaching Hospital (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-01-07
• Last Update Posted: 17 October 2016

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 400

Inclusion Criteria

1. Adults aged 18 years or older, either sex
2. Patients with closed ankle fractures that have required open reduction and internal fixation
3. Patients who are able to consent for themselves

Exclusion Criteria

1. Open fractures
2. Diabetics
3. Those with peripheral neuropathy, metabolic bone disorders and immunological disorders
4. Patients undergoing revision procedures
5. Patients with syndesmotic injury requiring screw removal prior to mobilisation
6. Those unable to use the Geko device

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. DVT rate<br>2. Time to Union

Secondary Outcome Measures

Name	Time	Method
1. Manchester - Oxford Foot and ankle questionnaire at end of 3 months<br>2. Time to return work